1. Home
  2. Clinical Topics
  3. FDA approves new drug for schizophrenia and new drug for lung cancer
Clinical TopicsDrugs and DevicesNewsOncologyWeb Exclusives

FDA approves new drug for schizophrenia and new drug for lung cancer

Share

On July 13, the U.S. Food and Drug Administration (FDA) approved

  • Rexulti (brexpiprazole) to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder. Read more
  • Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors harbor specific types of epidermal growth factor receptor gene mutations, as detected by an FDA-approved test. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts